Search research articles
Contact Us
Filters
Showing results (501-510 of 562) with videos related to
Page
of 57
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 21, 2007
Tumor immune escape by the loss of homeostatic chemokine expression
Andor Pivarcsi, Anja Müller, Andreas Hippe, et al.
Acta Neuropathologica
|
October 15, 2017
Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis
Ulrike Beyer, Frank Brand, Helge Martens, et al.
Acta Neuropathologica
|
June 20, 2015
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities
David E Reuss, Annekathrin Kratz, Felix Sahm, et al.
The Journal of Allergy and Clinical Immunology
|
August 2, 2016
Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells
Hannah H Chen, Norman Händel, Joanne Ngeow, et al.
Neuro-Oncology
|
March 21, 2022
Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis
Nan Qin, Eunice Paisana, Maike Langini, et al.
Neuro-Oncology
|
January 28, 2021
Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification
Cecile L Maire, Marceline M Fuh, Kerstin Kaulich, et al.
Virchows Archiv : an International Journal of Pathology
|
January 28, 2018
Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics
B Hirsch, V Endris, S Lassmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2015
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
Michael Weller, Ghazaleh Tabatabai, Bärbel Kästner, et al.
Cell Death & Disease
|
September 20, 2022
Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors
Lena Blümel, Nan Qin, Johannes Berlandi, et al.
Acta Neuropathologica
|
November 17, 2019
Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults
Christian Thomas, Annika Wefers, Susanne Bens, et al.
Page
of 57
Search research articles
Search
Showing results (501-510 of 562) with videos related to
Sort By:
Page
of 57
Proceedings of the National Academy of Sciences of the United States of America
|
November 21, 2007
Tumor immune escape by the loss of homeostatic chemokine expression
Andor Pivarcsi, Anja Müller, Andreas Hippe, et al.
Acta Neuropathologica
|
October 15, 2017
Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis
Ulrike Beyer, Frank Brand, Helge Martens, et al.
Acta Neuropathologica
|
June 20, 2015
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities
David E Reuss, Annekathrin Kratz, Felix Sahm, et al.
The Journal of Allergy and Clinical Immunology
|
August 2, 2016
Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells
Hannah H Chen, Norman Händel, Joanne Ngeow, et al.
Neuro-Oncology
|
March 21, 2022
Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis
Nan Qin, Eunice Paisana, Maike Langini, et al.
Neuro-Oncology
|
January 28, 2021
Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification
Cecile L Maire, Marceline M Fuh, Kerstin Kaulich, et al.
Virchows Archiv : an International Journal of Pathology
|
January 28, 2018
Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics
B Hirsch, V Endris, S Lassmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2015
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
Michael Weller, Ghazaleh Tabatabai, Bärbel Kästner, et al.
Cell Death & Disease
|
September 20, 2022
Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors
Lena Blümel, Nan Qin, Johannes Berlandi, et al.
Acta Neuropathologica
|
November 17, 2019
Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults
Christian Thomas, Annika Wefers, Susanne Bens, et al.
Page
of 57